Rhenman & Partners Asset Management AB Grows Stock Position in Tenet Healthcare Corporation $THC

Rhenman & Partners Asset Management AB increased its holdings in Tenet Healthcare Corporation (NYSE:THC) by 30.9% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 76,504 shares of the company’s stock after purchasing an additional 18,075 shares during the quarter. Rhenman & Partners Asset Management AB’s holdings in Tenet Healthcare were worth $15,203,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Caption Management LLC acquired a new position in Tenet Healthcare in the 3rd quarter valued at about $5,650,000. Hillsdale Investment Management Inc. raised its stake in Tenet Healthcare by 31.0% in the 3rd quarter. Hillsdale Investment Management Inc. now owns 22,800 shares of the company’s stock valued at $4,629,000 after purchasing an additional 5,400 shares during the last quarter. Eminence Capital LP acquired a new position in Tenet Healthcare in the 3rd quarter valued at about $225,263,000. GenTrust LLC acquired a new position in Tenet Healthcare in the 3rd quarter valued at about $895,000. Finally, Sirios Capital Management L P raised its stake in Tenet Healthcare by 100.9% in the 3rd quarter. Sirios Capital Management L P now owns 71,566 shares of the company’s stock valued at $14,531,000 after purchasing an additional 35,947 shares during the last quarter. Institutional investors and hedge funds own 95.44% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently weighed in on THC shares. Wall Street Zen downgraded shares of Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, May 11th. Weiss Ratings downgraded shares of Tenet Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, June 2nd. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of Tenet Healthcare in a research note on Wednesday, March 4th. Stephens dropped their price objective on shares of Tenet Healthcare from $275.00 to $260.00 and set an “overweight” rating for the company in a research note on Monday, May 4th. Finally, Wells Fargo & Company dropped their price objective on shares of Tenet Healthcare from $265.00 to $213.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. Eighteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, Tenet Healthcare presently has an average rating of “Moderate Buy” and an average target price of $244.16.

Insider Buying and Selling

In related news, Director Nadja West sold 3,000 shares of the stock in a transaction that occurred on Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total transaction of $532,050.00. Following the completion of the sale, the director owned 24,805 shares of the company’s stock, valued at approximately $4,399,166.75. This represents a 10.79% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director J Robert Kerrey sold 5,638 shares of the stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $174.52, for a total transaction of $983,943.76. Following the sale, the director directly owned 16,804 shares of the company’s stock, valued at approximately $2,932,634.08. This trade represents a 25.12% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.97% of the stock is currently owned by corporate insiders.

Tenet Healthcare Trading Up 0.9%

NYSE THC opened at $174.67 on Friday. The company has a 50-day moving average of $183.94 and a 200-day moving average of $199.94. The company has a market cap of $15.05 billion, a P/E ratio of 9.08, a P/E/G ratio of 1.43 and a beta of 1.28. Tenet Healthcare Corporation has a 12 month low of $146.60 and a 12 month high of $247.21. The company has a debt-to-equity ratio of 1.96, a current ratio of 1.36 and a quick ratio of 1.30.

Tenet Healthcare (NYSE:THC) last posted its earnings results on Thursday, April 30th. The company reported $4.82 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.21 by $0.61. The firm had revenue of $5.37 billion during the quarter, compared to the consensus estimate of $5.39 billion. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The company’s revenue was up 2.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $4.36 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. As a group, equities analysts predict that Tenet Healthcare Corporation will post 17.61 earnings per share for the current year.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.